JP2020533021A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533021A5 JP2020533021A5 JP2020534820A JP2020534820A JP2020533021A5 JP 2020533021 A5 JP2020533021 A5 JP 2020533021A5 JP 2020534820 A JP2020534820 A JP 2020534820A JP 2020534820 A JP2020534820 A JP 2020534820A JP 2020533021 A5 JP2020533021 A5 JP 2020533021A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- gla
- cells
- delivery molecule
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 claims 21
- 238000000034 method Methods 0.000 claims 20
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 229940096437 Protein S Drugs 0.000 claims 3
- 108010066124 Protein S Proteins 0.000 claims 3
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 3
- 102100028885 Vitamin K-dependent protein S Human genes 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 2
- 102100040120 Prominin-1 Human genes 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 2
- UHBYWPGGCSDKFX-VKHMYHEASA-N gamma-carboxy-L-glutamic acid Chemical compound OC(=O)[C@@H](N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-VKHMYHEASA-N 0.000 claims 2
- 102000043253 matrix Gla protein Human genes 0.000 claims 2
- 108010057546 matrix Gla protein Proteins 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 102100022749 Aminopeptidase N Human genes 0.000 claims 1
- 101100009548 Arabidopsis thaliana DHFS gene Proteins 0.000 claims 1
- 102100032912 CD44 antigen Human genes 0.000 claims 1
- -1 CD4f Proteins 0.000 claims 1
- 102100022641 Coagulation factor IX Human genes 0.000 claims 1
- 102100023804 Coagulation factor VII Human genes 0.000 claims 1
- 108010076282 Factor IX Proteins 0.000 claims 1
- 108010023321 Factor VII Proteins 0.000 claims 1
- 108010014173 Factor X Proteins 0.000 claims 1
- 102100031487 Growth arrest-specific protein 6 Human genes 0.000 claims 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 1
- 101000923005 Homo sapiens Growth arrest-specific protein 6 Proteins 0.000 claims 1
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 1
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims 1
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 claims 1
- 102100032816 Integrin alpha-6 Human genes 0.000 claims 1
- 102000004067 Osteocalcin Human genes 0.000 claims 1
- 108090000573 Osteocalcin Proteins 0.000 claims 1
- 102100037765 Periostin Human genes 0.000 claims 1
- 101710199268 Periostin Proteins 0.000 claims 1
- 101800004937 Protein C Proteins 0.000 claims 1
- 102000017975 Protein C Human genes 0.000 claims 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 1
- 101100216053 Saccharomycopsis fibuligera GLA1 gene Proteins 0.000 claims 1
- 101800001700 Saposin-D Proteins 0.000 claims 1
- 102100038081 Signal transducer CD24 Human genes 0.000 claims 1
- 108090000190 Thrombin Proteins 0.000 claims 1
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 claims 1
- 210000004504 adult stem cell Anatomy 0.000 claims 1
- 230000001640 apoptogenic effect Effects 0.000 claims 1
- 210000003969 blast cell Anatomy 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 229960004222 factor ix Drugs 0.000 claims 1
- 229940012413 factor vii Drugs 0.000 claims 1
- 229940012426 factor x Drugs 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 1
- 230000001114 myogenic effect Effects 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 230000004987 nonapoptotic effect Effects 0.000 claims 1
- 230000001582 osteoblastic effect Effects 0.000 claims 1
- 108010025221 plasma protein Z Proteins 0.000 claims 1
- 229960000856 protein c Drugs 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 210000003124 radial glial cell Anatomy 0.000 claims 1
- 229960004072 thrombin Drugs 0.000 claims 1
- 230000001228 trophic effect Effects 0.000 claims 1
- 239000002753 trypsin inhibitor Substances 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554533P | 2017-09-05 | 2017-09-05 | |
| US201762554530P | 2017-09-05 | 2017-09-05 | |
| US62/554,530 | 2017-09-05 | ||
| US62/554,533 | 2017-09-05 | ||
| US201762569411P | 2017-10-06 | 2017-10-06 | |
| US201762569403P | 2017-10-06 | 2017-10-06 | |
| US62/569,411 | 2017-10-06 | ||
| US62/569,403 | 2017-10-06 | ||
| US201762584565P | 2017-11-10 | 2017-11-10 | |
| US62/584,565 | 2017-11-10 | ||
| US201762593014P | 2017-11-30 | 2017-11-30 | |
| US62/593,014 | 2017-11-30 | ||
| PCT/US2018/049618 WO2019050997A1 (en) | 2017-09-05 | 2018-09-05 | LOAD DISTRIBUTION USEFUL IN STEM CELLS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020533021A JP2020533021A (ja) | 2020-11-19 |
| JP2020533021A5 true JP2020533021A5 (enExample) | 2021-10-14 |
| JP7365704B2 JP7365704B2 (ja) | 2023-10-20 |
Family
ID=63714024
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512854A Pending JP2020533976A (ja) | 2017-09-05 | 2018-09-05 | エキソソームを標的化する方法 |
| JP2020534820A Active JP7365704B2 (ja) | 2017-09-05 | 2018-09-05 | 幹細胞へのペイロードの送達 |
| JP2020534821A Pending JP2020533404A (ja) | 2017-09-05 | 2018-09-05 | 細胞内送達法 |
| JP2024041903A Pending JP2024073589A (ja) | 2017-09-05 | 2024-03-18 | エキソソームを標的化する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512854A Pending JP2020533976A (ja) | 2017-09-05 | 2018-09-05 | エキソソームを標的化する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020534821A Pending JP2020533404A (ja) | 2017-09-05 | 2018-09-05 | 細胞内送達法 |
| JP2024041903A Pending JP2024073589A (ja) | 2017-09-05 | 2024-03-18 | エキソソームを標的化する方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US11981723B2 (enExample) |
| EP (3) | EP3679128A1 (enExample) |
| JP (4) | JP2020533976A (enExample) |
| KR (2) | KR20200050975A (enExample) |
| CN (2) | CN111051500A (enExample) |
| AU (2) | AU2018328223A1 (enExample) |
| BR (2) | BR112020004319A2 (enExample) |
| CA (2) | CA3074291A1 (enExample) |
| IL (2) | IL272908A (enExample) |
| MX (2) | MX2020002250A (enExample) |
| PE (2) | PE20201263A1 (enExample) |
| SG (2) | SG11202001536PA (enExample) |
| WO (3) | WO2019050997A1 (enExample) |
| ZA (2) | ZA202000650B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014151535A1 (en) | 2013-03-15 | 2014-09-25 | Bayer Healthcare Llc | Gla domains as targeting agents |
| US20200368285A1 (en) | 2017-08-07 | 2020-11-26 | The Regents Of The University Of California | Platform for generating safe cell therapeutics |
| US11981723B2 (en) | 2017-09-05 | 2024-05-14 | GLAdiator Biosciences, Inc. | Method of targeting exosomes |
| EA202092684A1 (ru) | 2018-08-27 | 2021-03-11 | Ридженерон Фармасьютикалз, Инк. | Применение рамановской спектроскопии для последующей очистки |
| CN110036976B (zh) * | 2019-05-08 | 2021-12-07 | 华南农业大学 | 一种阻断鸡禽白血病病毒垂直传播的方法及其应用 |
| CN110423777A (zh) * | 2019-07-23 | 2019-11-08 | 河南科技大学 | 无荧光染料标记外泌体及其制备方法 |
| CN110711249B (zh) * | 2019-09-19 | 2020-10-27 | 北京化工大学 | 一种溶酶体膜包覆纳米颗粒的制备方法 |
| IL291968A (en) * | 2019-10-09 | 2022-06-01 | Mayo Found Medical Education & Res | Rabies megaloglutin virus and fusion polypeptides |
| KR102547446B1 (ko) * | 2019-11-29 | 2023-06-26 | 서울대학교산학협력단 | 무표지 폴리다이아세틸렌 리포좀 기반의 엑소좀의 검출 방법 |
| CN111803646B (zh) * | 2020-06-04 | 2022-07-05 | 苏州大学 | 一种实体肿瘤联合治疗组合物 |
| US20210393536A1 (en) * | 2020-06-23 | 2021-12-23 | Board Of Regents, The University Of Texas System | Methods and compositions related to extracellular vesicles |
| KR102659285B1 (ko) * | 2020-08-11 | 2024-04-22 | 경북대학교 산학협력단 | 암세포 유래 엑소좀에 선택적으로 결합하는 펩타이드 및 이의 용도 |
| CN112516110B (zh) * | 2020-10-13 | 2022-05-13 | 北京化工大学 | 一种细胞膜包覆纳米酶的方法 |
| CN112285195B (zh) * | 2020-10-27 | 2021-08-10 | 江南大学 | 一种牛奶外泌体的特征性糖蛋白标志物和牛奶外泌体的特征性标志物分离方法 |
| CN112553152B (zh) * | 2020-10-27 | 2024-09-17 | 重庆市铂而斐细胞生物技术有限公司 | 一种快速提高脂肪间充质干细胞外泌体产量的方法 |
| KR102285160B1 (ko) * | 2020-12-24 | 2021-08-03 | 주식회사 타임바이오 | 전구세포에서 유래한 다기능성 엑소좀을 포함하는 피부염 예방 또는 치료용 약학적 조성물 |
| KR102739746B1 (ko) * | 2021-10-25 | 2024-12-10 | 인하대학교 산학협력단 | 바르토넬라 헨셀라이 유래 세포외 소포체를 이용한 바르토넬라 감염증 진단 방법 |
| CN114940967B (zh) * | 2022-05-09 | 2024-05-31 | 中山大学 | 母乳细胞外囊泡及其在制备骨修复材料中的应用 |
| US20240327895A1 (en) * | 2022-12-30 | 2024-10-03 | Industrial Technology Research Institute | Composition for stabilizing cell-free nucleic acid and/or exosomal nucleic acid in blood, and agent and kit containing the same |
| CN116421738B (zh) * | 2023-02-28 | 2024-03-19 | 中国医科大学附属第一医院 | 捕获抗原的溶瘤病毒及其药物组合与制备和应用 |
| KR20240154736A (ko) * | 2023-04-18 | 2024-10-28 | 가톨릭대학교 산학협력단 | 면역관문 억제제의 표적화된 전달을 위한 세포외소포체의 용도 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
| US4938948A (en) | 1985-10-07 | 1990-07-03 | Cetus Corporation | Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies |
| US5475085A (en) | 1991-02-07 | 1995-12-12 | Molecumetics, Ltd. | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| JPH06505486A (ja) | 1991-02-07 | 1994-06-23 | モレキュメティクス，リミティド | βターンおよびβバルジのコンフォメーション的に制限された模倣物およびそれらを含有するペプチド |
| GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
| US5329028A (en) | 1992-08-05 | 1994-07-12 | Genentech, Inc. | Carbohydrate-directed cross-linking reagents |
| DE69333397T2 (de) | 1992-08-27 | 2004-12-09 | Bioclones (Proprietary) Ltd., Sandton | Retro-, inverso-, und retro-inverso synthetische peptidanaloge |
| US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
| US5446128A (en) | 1993-06-18 | 1995-08-29 | The Board Of Trustees Of The University Of Illinois | Alpha-helix mimetics and methods relating thereto |
| AU6985594A (en) | 1993-06-30 | 1995-01-24 | Bonno Nammen Bouma | Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| US5597457A (en) | 1995-01-23 | 1997-01-28 | The Regents Of The University Of California | System and method for forming synthetic protein crystals to determine the conformational structure by crystallography |
| US5929237A (en) | 1995-10-27 | 1999-07-27 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| US5840833A (en) | 1995-10-27 | 1998-11-24 | Molecumetics, Ltd | Alpha-helix mimetics and methods relating thereto |
| GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
| CA2276091A1 (en) | 1996-12-27 | 1998-07-09 | Mochida Pharmaceutical Co., Ltd. | Cell membrane-directed drugs |
| US6093573A (en) | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
| US7067109B1 (en) | 1998-07-13 | 2006-06-27 | Board Of Regents, The University Of Texas System | Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| CA2340074A1 (en) | 1998-08-13 | 2000-02-24 | American Home Products Corporation | Crystal structure of escherichia coli gdp-fucose synthetase and methods of its use |
| AU4218799A (en) | 1998-08-25 | 2000-03-14 | Scripps Research Institute, The | Methods and systems for predicting protein function |
| US6801860B1 (en) | 1999-02-15 | 2004-10-05 | Genetics Institute, Llc | Crystal structure of cPLA2 and methods of identifying agonists and antagonists using same |
| US20040001827A1 (en) | 2002-06-28 | 2004-01-01 | Dennis Mark S. | Serum albumin binding peptides for tumor targeting |
| JP2002003407A (ja) | 2000-06-20 | 2002-01-09 | Medei Sci Puraningu:Kk | ハイドロキシアパタイトカルシウム指向性薬物輸送担体 |
| WO2003017032A2 (en) | 2001-08-14 | 2003-02-27 | Dana-Farber Cancer Institute, Inc. | Computer-based methods of designing molecules |
| US7807174B2 (en) | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| EP1644504B8 (en) | 2003-06-19 | 2010-06-02 | Bayer HealthCare LLC | Factor vii or viia gla domain variants |
| JP2007536898A (ja) | 2003-07-01 | 2007-12-20 | セルテック アール アンド ディ リミテッド | 修飾抗体Ｆａｂフラグメント |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| UA88272C2 (ru) * | 2003-08-15 | 2009-10-12 | Борд Оф Трастиз Оф Зе Юниверсити Оф Иллинойс | Применение полипептидов семейства купредоксина в лечении рака |
| WO2005079766A2 (en) | 2004-02-20 | 2005-09-01 | Novo Nordisk A/S | Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| GB0411186D0 (en) | 2004-05-19 | 2004-06-23 | Celltech R&D Ltd | Biological products |
| CN102816742B (zh) | 2004-05-26 | 2014-04-09 | 普西奥克瑟斯医疗有限公司 | 用于治疗癌症的嵌合腺病毒 |
| US7511016B2 (en) | 2004-07-07 | 2009-03-31 | Mosamedix B.V. | Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| EP1781782B1 (en) | 2004-08-17 | 2010-05-26 | CSL Behring GmbH | Modified vitamin k dependent polypeptides |
| ES2565543T3 (es) * | 2005-01-24 | 2016-04-05 | Board Of Regents, The University Of Texas System | Construcciones de fusión a Fc de unión a fosfatidilserina y su uso terapéutico |
| KR100987547B1 (ko) * | 2006-06-01 | 2010-10-12 | 가톨릭대학교 산학협력단 | 냉동보관된 제대혈 줄기세포로부터 초기 세포사를 측정하는조성물, 키트 및 그 방법 |
| EP2094284A2 (en) | 2006-12-22 | 2009-09-02 | Bayer Schering Pharma AG | Generation of oncolytic adenoviruses and uses thereof |
| JP5130580B2 (ja) | 2007-01-17 | 2013-01-30 | 独立行政法人放射線医学総合研究所 | 幹細胞における低線量被ばくの検出マーカー、及び該マーカーを用いる幹細胞での低線量被ばくレベルを推定又は検出する方法 |
| NZ579985A (en) | 2007-04-13 | 2012-02-24 | Catalyst Biosciences Inc | Modified factor vii polypetides and uses thereof |
| KR100968839B1 (ko) | 2008-02-25 | 2010-07-09 | 경북대학교 산학협력단 | 포스파티딜세린과 특이적으로 결합하는 폴리펩티드 및 이의용도 |
| TWI538916B (zh) * | 2008-04-11 | 2016-06-21 | 介控生化科技公司 | 經修飾的因子vii多肽和其用途 |
| WO2010006136A2 (en) * | 2008-07-09 | 2010-01-14 | Mayo Foundation For Medical Education And Research | Adenovirus targeting |
| PE20110598A1 (es) | 2008-10-02 | 2011-08-31 | Respivert Ltd | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 |
| WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| US8283167B2 (en) | 2009-02-11 | 2012-10-09 | Clear Vascular Inc. | Preparation of annexin derivatives |
| US8647620B2 (en) | 2009-06-25 | 2014-02-11 | The University Of North Carolina At Chapel Hill | Chimeric factor VII molecules |
| EP2529007B1 (en) | 2010-01-26 | 2017-07-12 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
| US20140004601A1 (en) | 2010-12-20 | 2014-01-02 | Agency For Science, Technology And Research | Method of purifying exosomes |
| EP2684045B2 (en) | 2011-03-09 | 2023-03-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods to characterize patients suffering from hemolysis |
| CN103797028B (zh) | 2011-07-18 | 2017-08-25 | Iba 股份有限公司 | 使靶细胞可逆染色的方法 |
| HK1206601A1 (en) | 2012-04-02 | 2016-01-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
| TWI497845B (zh) | 2012-07-18 | 2015-08-21 | Murata Manufacturing Co | Coaxial connector |
| EP2877211A4 (en) * | 2012-07-25 | 2016-02-10 | Salk Inst For Biological Studi | CONTROL OF INTERACTION BETWEEN TAM LIGANDS AND LIPID MEMBRANES WITH EXPOSED PHOSPHATIDYL SERININE |
| CN103655475B (zh) | 2012-09-19 | 2020-04-28 | 乔治敦大学 | 靶向的脂质体 |
| WO2014151535A1 (en) | 2013-03-15 | 2014-09-25 | Bayer Healthcare Llc | Gla domains as targeting agents |
| EP3872090A1 (en) * | 2014-03-11 | 2021-09-01 | Molecular Templates, Inc. | Proteins comprising amino-terminal proximal shiga toxin a subunit effector regions and cell-targeting immunoglobulin-type binding regions |
| EP3137488B1 (en) * | 2014-06-11 | 2019-01-02 | Molecular Templates, Inc. | Protease-cleavage resistant, shiga toxin a subunit effector polypeptides and cell-targeting molecules comprising the same |
| CN105457032A (zh) | 2014-08-11 | 2016-04-06 | 中国人民解放军军事医学科学院毒物药物研究所 | 靶向癌干细胞的碳纳米管-盐霉素药物递送系统、其制备方法及用途 |
| WO2017118764A1 (en) * | 2016-01-07 | 2017-07-13 | Thomas Brocker | Novel approaches for the in vivo and in vitro visualization of dying cells |
| CN105567642B (zh) | 2016-02-01 | 2019-07-12 | 中国科学院生物物理研究所 | 一种着色性干皮病人多能干细胞的制备方法 |
| US11981723B2 (en) | 2017-09-05 | 2024-05-14 | GLAdiator Biosciences, Inc. | Method of targeting exosomes |
-
2018
- 2018-09-05 US US16/643,997 patent/US11981723B2/en active Active
- 2018-09-05 WO PCT/US2018/049618 patent/WO2019050997A1/en not_active Ceased
- 2018-09-05 MX MX2020002250A patent/MX2020002250A/es unknown
- 2018-09-05 US US16/643,964 patent/US20200407422A1/en not_active Abandoned
- 2018-09-05 PE PE2020000281A patent/PE20201263A1/es unknown
- 2018-09-05 KR KR1020207007278A patent/KR20200050975A/ko active Pending
- 2018-09-05 JP JP2020512854A patent/JP2020533976A/ja active Pending
- 2018-09-05 BR BR112020004319-2A patent/BR112020004319A2/pt not_active IP Right Cessation
- 2018-09-05 AU AU2018328223A patent/AU2018328223A1/en not_active Abandoned
- 2018-09-05 JP JP2020534820A patent/JP7365704B2/ja active Active
- 2018-09-05 PE PE2020000305A patent/PE20201462A1/es unknown
- 2018-09-05 EP EP18779855.8A patent/EP3679128A1/en not_active Withdrawn
- 2018-09-05 AU AU2018330427A patent/AU2018330427A1/en not_active Abandoned
- 2018-09-05 CN CN201880056194.3A patent/CN111051500A/zh active Pending
- 2018-09-05 JP JP2020534821A patent/JP2020533404A/ja active Pending
- 2018-09-05 CA CA3074291A patent/CA3074291A1/en active Pending
- 2018-09-05 EP EP18789264.1A patent/EP3679129A1/en not_active Withdrawn
- 2018-09-05 BR BR112020003945-4A patent/BR112020003945A2/pt not_active IP Right Cessation
- 2018-09-05 WO PCT/US2018/049624 patent/WO2019051002A1/en not_active Ceased
- 2018-09-05 US US16/643,942 patent/US20200407421A1/en not_active Abandoned
- 2018-09-05 EP EP18779854.1A patent/EP3679127A1/en active Pending
- 2018-09-05 SG SG11202001536PA patent/SG11202001536PA/en unknown
- 2018-09-05 MX MX2020002442A patent/MX2020002442A/es unknown
- 2018-09-05 SG SG11202001535RA patent/SG11202001535RA/en unknown
- 2018-09-05 WO PCT/US2018/049619 patent/WO2019050998A1/en not_active Ceased
- 2018-09-05 KR KR1020207005896A patent/KR20200050961A/ko not_active Ceased
- 2018-09-05 CA CA3074678A patent/CA3074678A1/en active Pending
- 2018-09-05 CN CN201880057602.7A patent/CN111065733A/zh active Pending
-
2020
- 2020-01-30 ZA ZA2020/00650A patent/ZA202000650B/en unknown
- 2020-02-18 ZA ZA2020/01012A patent/ZA202001012B/en unknown
- 2020-02-26 IL IL272908A patent/IL272908A/en unknown
- 2020-02-27 IL IL272942A patent/IL272942A/en unknown
-
2024
- 2024-03-18 JP JP2024041903A patent/JP2024073589A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533021A5 (enExample) | ||
| Lombaert et al. | Concise review: salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids | |
| Dissanayaka et al. | In vitro analysis of scaffold-free prevascularized microtissue spheroids containing human dental pulp cells and endothelial cells | |
| Zhang et al. | Endothelial differentiation of amniotic fluid–derived stem cells: synergism of biochemical and shear force stimuli | |
| Lv et al. | Concise review: the surface markers and identity of human mesenchymal stem cells | |
| Lee et al. | Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction | |
| Fitzsimmons et al. | Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering | |
| Dykstra et al. | Concise review: fat and furious: harnessing the full potential of adipose-derived stromal vascular fraction | |
| Rossi et al. | Advances in musculoskeletal tissue engineering: moving towards therapy | |
| Rota et al. | Human amniotic fluid stem cell preconditioning improves their regenerative potential | |
| Brzoska et al. | Sdf‐1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells | |
| Paunescu et al. | Tumour‐associated fibroblasts and mesenchymal stem cells: more similarities than differences | |
| Chen et al. | Cellular kinetics of perivascular MSC precursors | |
| JP6882161B2 (ja) | 改善された幹細胞組成物 | |
| Winnier et al. | Isolation of adipose tissue derived regenerative cells from human subcutaneous tissue with or without the use of an enzymatic reagent | |
| Hassan et al. | Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair | |
| Fierro et al. | Hypoxic pre-conditioning increases the infiltration of endothelial cells into scaffolds for dermal regeneration pre-seeded with mesenchymal stem cells | |
| Lin et al. | Small intestinal submucosa-derived extracellular matrix bioscaffold significantly enhances angiogenic factor secretion from human mesenchymal stromal cells | |
| Chen et al. | Effects of cobalt chloride on the stem cell marker expression and osteogenic differentiation of stem cells from human exfoliated deciduous teeth | |
| RU2013156357A (ru) | Лечение дегенеративных изменений межпозвоночных дисков с использованием клеток, полученных из ткани пуповины человека | |
| Wu et al. | Exosomes from mesenchymal stem cells induce the conversion of hepatocytes into progenitor oval cells | |
| Pei et al. | Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells | |
| Bae et al. | The significance of SDF-1α-CXCR4 axis in in vivo angiogenic ability of human periodontal ligament stem cells | |
| El-Haibi et al. | Mesenchymal stem cells in the pathogenesis and therapy of breast cancer | |
| Gomes et al. | The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas |